According to the Longevity Biotechnology Association, a global nonprofit focused on preventing diseases associated with aging and extending people’s health spans, longevity drugs are medications that ...
It seems like everywhere we turn, someones talking about glucagon-like peptide-1 (GLP-1) receptor agonist medications and for good reason. You more than likely already know the names: semaglutide ...
Scientists are studying whether GLP-1 medications may slow biological aging—not just help people lose weight.
Obesity is a global health concern with new medication treatment options. So far, research on how programs with newer anti-obesity medication (AOM) for the moderate- to high-risk population can ...
It seems like everyone is focused on improving their longevity and health span right now, doing whatever they can to prevent age-related diseases, extend the number of years they spend in good health, ...
Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...
Obesity is a risk factor for several cancers, but the mechanistic basis is poorly understood. We sought to identify circulating metabolites mediating the effect of obesity on the risk of eight common ...
A new study suggests it could help people with diabetes and obesity lose weight while avoiding some common side effects ...
High-fat diets and obesity reshape astrocytes—star-shaped brain cells in the striatum that help regulate pleasure from eating. French researchers discovered that tweaking these cells in mice not only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results